Your browser doesn't support javascript.
loading
Primary Omicron infection elicits weak antibody response but robust cellularimmunity in children
Alexander C Dowell; Tara Lancaster; Rachel Bruton; Georgina Ireland; Panagiota Sylla; Jianmin Zuo; Sam Scott; Azar Jardin; Jusnara Begum; Thomas Roberts; Christine Stephens; Umayr Amin; Shabana Ditta; Rebecca Shepherdson; Annable Powell; Andrew Brent; Bernadette Brent; Frances Baawuah; Ifeanyichukwu Okike; Joanna Beckmann; Shazaad Ahmad; Felicity Aiano; Joanna Garstang; Mary Ramsay; Rafaq Azad; Dagmar Waiblinger; Brian Willet; John Wright; Shamez Ladhani; Paul Moss.
Afiliação
  • Alexander C Dowell; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Tara Lancaster; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Rachel Bruton; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Georgina Ireland; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Panagiota Sylla; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Jianmin Zuo; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Sam Scott; MRC-University of Glasgow Centre for Virus Research, 464 Bearsden Road, Glasgow G61-1QH, UK
  • Azar Jardin; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Jusnara Begum; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Thomas Roberts; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Christine Stephens; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Umayr Amin; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  • Shabana Ditta; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.
  • Rebecca Shepherdson; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.
  • Annable Powell; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Andrew Brent; Oxford University Hospitals NHS Foundation Trust, Old Road, Oxford OX3 7HE
  • Bernadette Brent; Oxford University Hospitals NHS Foundation Trust, Old Road, Oxford OX3 7HE
  • Frances Baawuah; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Ifeanyichukwu Okike; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Joanna Beckmann; East London NHS Foundation Trust, 9 Allie Street, London E1 8DE, UK
  • Shazaad Ahmad; Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK
  • Felicity Aiano; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Joanna Garstang; Birmingham Community Healthcare NHS Trust, Holt Street, Aston B7 4BN, UK
  • Mary Ramsay; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Rafaq Azad; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.
  • Dagmar Waiblinger; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.
  • Brian Willet; MRC-University of Glasgow Centre for Virus Research, 464 Bearsden Road, Glasgow G61-1QH, UK
  • John Wright; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.
  • Shamez Ladhani; Immunisation Department, UK Health Security Agency, 61 Colindale Avenue, London, United Kingdom
  • Paul Moss; Institute of Immunology & Immunotherapy, Collage of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK
Preprint em En | PREPRINT-BIORXIV | ID: ppbiorxiv-501570
ABSTRACT
The Omicron variant of SARS-CoV-2 is now globally dominant but despite high prevalence little is known regarding the immune response in children. We determined the antibody and cellular immune response following Omicron infection in children aged 6-14 years and related this to prior SARS-CoV-2 infection and vaccination status. Primary Omicron infection elicited a weak antibody response and only 53% of children developed detectable neutralising antibodies. In contrast, children with secondary Omicron infection following prior infection with a pre-Omicron variant developed 24-fold higher antibody titres and neutralisation of Omicron. Vaccination elicited the highest levels of antibody response and was also strongly immunogenic following prior natural infection with Omicron. Cellular responses against Omicron were robust and broadly equivalent in all study groups. These data reveal that primary Omicron infection elicits a weak humoral immune response in children and may presage a clinical profile of recurrent infection as seen with antecedent seasonal coronaviruses. Vaccination may represent the most effective approach to control infection whilst cellular immunity should offer strong clinical protection.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-BIORXIV Tipo de estudo: Experimental_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint